guest ::
| Home > Publications Database > Dataset: USP9X phosphopeptide mapping > print |
| 001 | 249924 | ||
| 005 | 20240118161500.0 | ||
| 037 | _ | _ | |a DZNE-2023-00239 |
| 100 | 1 | _ | |a Gloeckner, Christian Johannes |0 P:(DE-2719)2811291 |b 0 |e Last author |
| 245 | _ | _ | |a Dataset: USP9X phosphopeptide mapping |
| 260 | _ | _ | |c 2020 |b PRoteomics IDEntifications Database |
| 336 | 7 | _ | |a MISC |2 BibTeX |
| 336 | 7 | _ | |a Dataset |b dataset |m dataset |0 PUB:(DE-HGF)32 |s 1705590871_9225 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a Chart or Table |0 26 |2 EndNote |
| 336 | 7 | _ | |a Dataset |2 DataCite |
| 336 | 7 | _ | |a DATA_SET |2 ORCID |
| 336 | 7 | _ | |a ResearchData |2 DINI |
| 520 | _ | _ | |a We previously identified the deubiquitylase USP9X as a G2/M-specific CDC14B interactor (PXD012732). The functional connection of these proteins has been further investigated by a quantitative comparison of USP9X phosphorylation in WT vs CDC14B-overexpressing HEK 293Tcells (ATCC® CRL-3216™). The approach identified USP9X serine 2563 as a specific CDC14B target. Phosphorylation at USP9XS2563 has been confirmed by in-house phosphospecific antibodies. |
| 536 | _ | _ | |a 352 - Disease Mechanisms (POF4-352) |0 G:(DE-HGF)POF4-352 |c POF4-352 |f POF IV |x 0 |
| 787 | 0 | _ | |a Dietachmayr, Michael et.al. |d [London] : Nature Publishing Group UK, 2020 |i RelatedTo |0 DZNE-2020-01409 |r |t Antagonistic activities of CDC14B and CDK1 on USP9X regulate WT1-dependent mitotic transcription and survival. |
| 856 | 4 | _ | |u https://www.ebi.ac.uk/pride/archive/projects/PXD012733 |
| 909 | C | O | |p VDB |o oai:pub.dzne.de:249924 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 0 |6 P:(DE-2719)2811291 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Neurodegenerative Diseases |1 G:(DE-HGF)POF4-350 |0 G:(DE-HGF)POF4-352 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Disease Mechanisms |x 0 |
| 914 | 1 | _ | |y 2020 |
| 920 | 1 | _ | |0 I:(DE-2719)1210007 |k AG Gloeckner |l Functional Neuroproteomics and Translational Biomarkers in Neurodegenerative Diseases |x 0 |
| 980 | _ | _ | |a dataset |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-2719)1210007 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|